期刊文献+

SARS治疗中应用糖皮质激素致糖尿病危险应予以重视 被引量:37

Be alert of the risk of glucocorticoid-induced diabetes in the management of severe acute respiratory syndrome
原文传递
导出
摘要 因早期、大剂量、长疗程应用糖皮质激素治疗严重急性呼吸综合征 (SARS)从而诱发糖尿病已成为十分突出的临床问题 ,提示该疗法应严格掌握适应症和禁忌症。此类糖尿病的治疗原则与 2型糖尿病大致相同 ,但降糖治疗方案宜充分考虑其下午严重高血糖常伴空腹低血糖的特点。 It has become a prominent clinical problem that diabetes was induced by early long-term use of large-dose glucocorticoid for treating severe acute respiratory syndrome (SARS), which suggesting that indication and contraindication of glucocorticoid therapy should be followed strictly. Principles of treating the secondary diabetes induced by glucocorticoid are similar to that used in type 2 diabetes, however, the feature of severe afternoon hyperglycemia combined with fasting hypoglycemia should be taken into account in the protocol design.
作者 李光伟
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2004年第1期1-2,共2页 Chinese Journal of Endocrinology and Metabolism
关键词 SARS 治疗 糖皮质激素 糖尿病 Severe actue respiratory syndrome Glucocorticoids Diabetes mellitus
  • 相关文献

参考文献3

二级参考文献10

共引文献7

同被引文献350

引证文献37

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部